Combined kidney and bone marrow transplantation for immune tolerance
Official title: Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction Between Matched Sibling Donor-recipient Pairs
Run by Rabin Medical Center · NCT05086003 · Data updated 2026-11-12
This study is testing if getting a kidney and bone marrow transplant from a matched sibling can help people stop taking immune-suppressing drugs without their body rejecting the kidney.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Rabin Medical Center Academic / other |
| Locations | 1 site (Petah Tikva) |
| Status | Recruiting |
| Started | January 19, 2016 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | October 28, 2021 |
| Trial ID | NCT05086003 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with matched sibling donors and no contraindications to the required therapies.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have infections such as HIV, HBV, or HCV, as well as those with a history of malignancy, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the combined transplantation of kidney and bone marrow from HLA-matched sibling donor-recipient pairs to induce immune tolerance, allowing for the potential discontinuation of immunosuppressive therapy without kidney rejection. Hematopoietic stem cells are collected from the donor weeks prior to the kidney transplant, and after the transplant, the recipient undergoes conditioning therapy followed by the infusion of the stem cell graft. The goal is to maintain mixed donor chimerism for over six months, which may enable the tapering off of immunosuppression.
Why it matters
Potential benefit: If successful, this approach could significantly reduce or eliminate the need for lifelong immunosuppressive therapy in kidney transplant recipients.
How similar studies have gone: While the approach of combining kidney and bone marrow transplantation for immune tolerance is innovative, similar studies have shown promise in the field of transplantation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age older than 18 years * Matched siblings * No contra-indication to thymoglobuline or total lymphoid irradiation Exclusion Criteria: * Pregnant women or breast feeding * Infection with HIV, HBV or HCV * Previous or presnt malignancy
Where it's running
-
Rabin Medical Center
Petah Tikva, Israel Recruiting
Study contacts
- Principal investigator: Moshe Yeshurun, MD — Institution of Hematology, Rabin Medical Center
- Study coordinator: Moshe Yeshurun, MD
- Email: moshe.yeshurun@gmail.com
- Phone: 0526015543
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pilates exercises to improve balance, fatigue, and quality of life after kidney transplant
This study tests whether adding Pilates to standard physical therapy helps people aged 20–50 after a kidney transplant feel steadier, less fatigued, and have a better quality of life.
-
Transversalis fascia plane block to reduce pain after kidney transplant
See if a transversalis fascia plane block can reduce pain and opioid use after kidney transplant for adults aged 18–65 with ASA III.
-
Preoperative sensory modulation room to reduce pain, anxiety, and improve sleep for living kidney donors and recipients
The team will try a short preoperative session in a sensory modulation room to see if it lowers postoperative pain, reduces anxiety, and improves sleep for adult living kidney donors and transplant recipients.
-
Emotion-focused therapy to improve emotion regulation and well-being after kidney transplant
This project will try an emotion-focused therapy to see if it helps adults who have had a kidney transplant manage their emotions and feel better.
-
Remimazolam infusion for adults undergoing kidney transplant
This will test whether a continuous remimazolam infusion gives consistent sedation and predictable blood levels in adults having kidney transplants.
-
Comparing muscle function and frailty in kidney transplant recipients
This study looks at how weak breathing muscles affect the overall health and recovery of people who have received a kidney transplant.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.